Richard De Schutter has been elected chairman of Incyte’s board of directors, the Palo Alto, Calif. company said earlier this week.

De Schutter, who has served on Incyte’s board since January 2002, was previously chairman and CEO of DuPont pharmaceuticals from January to October 2001. Prior to holding the DuPont position, De Schutter was vice-chairman, chief administrative officer and a director at Monsanto, after Monsanto acquired Searle, where De Schutter had been chairman and CEO.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.